Clinical Trial Update: Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating botulinum toxin (Botox, onabotulinumtoxinA) for Empty Nose Syndrome and atrophic rhinitis was terminated; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrophic Rhinitis
• Empty Nose Syndrome

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Mayo Clinic | Conditions: Empty Nose Syndrome, Atrophic Rhinitis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-02-13